Related Experiment Video
Updated: Apr 19, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease
1Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, kaorihayashi@a3.keio.jp.
Abstract:
Recently emerging evidence has shown that epigenetic mechanisms are involved in initiation and progression of various diseases, including kidney diseases. In the present article, we review the current data regarding the role of epigenetic modulation in chronic kidney disease (CKD) and kidney fibrosis, including DNA methylation and histone modification. Especially we focused on the role of transcription factors in epigenetic modulation and the possibility of therapeutic target of CKD. We have recently reported that transcription factor Kruppel-like factor 4 (also known as gut-enriched Kruppel-like factor) is expressed in kidney podocytes (visceral epithelial cells) and modulates podocyte phenotype by gene-selective epigenetic control. Targeting transcription factors for epigenetic modification may be a good candidate for remission and regression of CKD. It is necessary for the therapy of CKD with an epigenetic-based approach to investigate organ-, tissue-, or gene-specific treatment methods for reduction of side effects.
Insights
Epigenetic mechanisms, including DNA methylation and histone modification, are crucial in chronic kidney disease (CKD) progression. Targeting transcription factors offers a promising therapeutic strategy for CKD remission.
Area of Science:
- Nephrology
- Epigenetics
- Molecular Biology
Background:
- Emerging evidence implicates epigenetic mechanisms in the initiation and progression of various diseases, including kidney diseases.
- Chronic kidney disease (CKD) and kidney fibrosis are complex conditions influenced by epigenetic factors.
- Understanding these mechanisms is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To review current data on epigenetic modulation in CKD and kidney fibrosis.
- To explore the role of transcription factors in epigenetic regulation within the kidney.
- To assess the therapeutic potential of targeting epigenetic modifications for CKD treatment.
Main Methods:
- Review of existing literature on epigenetic mechanisms in kidney disease.
- Focus on DNA methylation and histone modification.
- Analysis of the role of specific transcription factors, such as Kruppel-like factor 4 (KLF4).
Main Results:
- Epigenetic modulation, including DNA methylation and histone modification, plays a significant role in CKD and kidney fibrosis.
- Transcription factors are key regulators of epigenetic processes in kidney cells.
- Kruppel-like factor 4 (KLF4) is expressed in kidney podocytes and influences their phenotype through epigenetic control.
Conclusions:
- Targeting transcription factors for epigenetic modification presents a potential therapeutic avenue for CKD remission and regression.
- Organ-, tissue-, and gene-specific epigenetic-based therapies are necessary to minimize side effects in CKD treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

